Ysnore Spray
FDA Label NDC 62587-219

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Y Snore for the product Ysnore (NDC 62587-219). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding homeopathic purpose, uses, warnings, otc - pregnancy or breast feeding, otc - keep out of reach of children, otc - stop use, directions, inactive ingredients, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Homeopathic Purpose

Active IngredientsPurpose
Dioscorea Villosa 2x HPUSReduces irritation of nasal Passages
Zingiber Officianle 2x HPUS....

Uses

Clinically proven to reduce or stop the symptoms of snoring.

Warnings

• Do not use on children under 12 years of age.

• This product is not intended to treat sleep apnea. See a physician if symptoms of sleep apnea occur.

Otc - Pregnancy Or Breast Feeding

• If pregnant or breast-feeding, ask a health professional before use.

Otc - Keep Out Of Reach Of Children

• Keep out of the reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Otc - Stop Use

• Stop use and ask a physician if symptoms do not improve in 14 days, or worsen.

Directions

Use only as directed
• Shake well before use.
• With head upright 1 or 2 sprays at the base of each nostril prior to sleep.
• Store at room temperature not to exceed 80° F.
• For individual use only.
• For best results daily use is required.

Inactive Ingredients

benzalkonium chloride, ethanol, glycerin, purified water, and sodium chloride.

* Please review the disclaimer below.